The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
85-96
Author(s):
L. A. Stivala, O. Cazzalini and E. Prosperi
Chronic Myelogenous Leukemia
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
3-13
Author(s):
Robert P. Hasserjian
Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
14-29
Author(s):
Robert P. Hasserjian
Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
30-34
Author(s):
Cherie H. Dunphy
Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
44-51
Author(s):
Cherie H. Dunphy
Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
475-487
Author(s):
T. Ai, H. Cui and L. Chen
Targeting Ion Channels in Leukemias: A New Challenge for Treatment
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
683-696
Author(s):
A. Arcangeli, S. Pillozzi and A. Becchetti
The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for the Photodynamic Therapy
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
799-807
Author(s):
L. E. Xodo, V. Rapozzi, M. Zacchigna, S. Drioli and S. Zorzet
Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
714-735
Author(s):
V. Shoshan-Barmatz and M. Golan
Cancer Regulator MicroRNA: Potential Relevance in Diagnosis, Prognosis and Treatment of Cancer
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
461-474
Author(s):
G. Fiorucci, M. V. Chiantore, G. Mangino, Z. A. Percario, E. Affabris and G. Romeo